Holen Sie sich die Stockscreener-App
14.89
2.69%
0.39
Schlusskurs vom Vortag:
$14.50
Offen:
$14.37
24-Stunden-Volumen:
45,214
Relative Volume:
0.66
Marktkapitalisierung:
$291.24M
Einnahmen:
$38.63M
Nettoeinkommen (Verlust:
$1.50M
KGV:
157.90
EPS:
0.0943
Netto-Cashflow:
$5.97M
1W Leistung:
-5.52%
1M Leistung:
-8.54%
6M Leistung:
+43.17%
1J Leistung:
+51.32%
1-Tages-Spanne:
$14.27
$15.56
1-Wochen-Bereich:
$14.27
$15.87
52-Wochen-Spanne:
$7.84
$17.92
Brainsway Ltd Adr Stock (BWAY) Company Profile
Firmenname
Brainsway Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie BWAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BWAY
Brainsway Ltd Adr
|
14.89 | 283.63M | 38.63M | 1.50M | 5.97M | 0.0943 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Brainsway Ltd Adr Stock (BWAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-11-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-03-03 | Eingeleitet | Loop Capital | Buy |
| 2021-07-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-20 | Eingeleitet | Northland Capital | Outperform |
| 2019-05-13 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-05-13 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2019-05-13 | Eingeleitet | Oppenheimer | Outperform |
| 2019-05-13 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Brainsway Ltd Adr Aktie (BWAY) Neueste Nachrichten
FY2025 EPS Estimate for Brainsway Decreased by Analyst - Defense World
Northland Capmk Reduces Earnings Estimates for Brainsway - MarketBeat
Northland Capmk Predicts Weaker Earnings for Brainsway - Defense World
BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21 - GlobeNewswire Inc.
Brainsway (NASDAQ:BWAY) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Brainsway (BWAY) Projected to Post Earnings on Tuesday - Defense World
Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year? - sharewise.com
HC Wainwright Has Bearish Forecast for Brainsway Q4 Earnings - MarketBeat
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run? - sharewise.com
BrainsWay secures two more U.S. mental health provider investments By Investing.com - Investing.com
Are Medical Stocks Lagging Alkermes (ALKS) This Year? - sharewise.com
MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy - The Globe and Mail
Brainsway (NASDAQ:BWAY) Shares Up 1.9%Here's What Happened - MarketBeat
Do Options Traders Know Something About Brainsway Stock We Don't? - sharewise.com
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Sees Large Increase in Short Interest - MarketBeat
BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care - sharewise.com
Insider Trading At ESS Tech Inc (NYSE: GWH): What Did We Note? - stocksregister.com
Why Buying The Brainsway Ltd ADR (NASDAQ: BWAY) Stock Today Might Make Sense - stocksregister.com
Is Robo.ai Inc (NASDAQ: AIIO) Stock Good For Medium-Term Investing? - stocksregister.com
Acadian Asset Management LLC Decreases Holdings in Brainsway Ltd. Sponsored ADR $BWAY - Defense World
Brainsway stock surges after FDA clears accelerated depression treatment - Investing.com
Short Interest in Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Declines By 20.1% - MarketBeat
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Short Interest Up 191.8% in August - Defense World
Trexquant Investment LP Takes $129,000 Position in Brainsway Ltd. Sponsored ADR $BWAY - Defense World
Brainsway Ltd. Sponsored ADR $BWAY Shares Sold by DAFNA Capital Management LLC - MarketBeat
Brainsway’s (BWAY) Buy Rating Reaffirmed at HC Wainwright - Defense World
Brainsway stock maintains Buy rating at H.C. Wainwright after strategic investments By Investing.com - Investing.com
BWAY Shares Rise on Strategic Investment in Neurolief's At-Home Care - sharewise.com
Neurolief Prepares for Launch of its Proliv™Rx System for Major Depressive Disorder with Strategic Investment from BrainsWay - Barchart.com
BrainsWay invests in Neurolief ahead of depression device launch By Investing.com - Investing.com
BrainsWay invests $2.3 million in Axis mental health services provider By Investing.com - Investing.com
Phibro Animal Health Corporation (PAHC) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Are Medical Stocks Lagging Biotricity (BTCY) This Year? - NewsBreak: Local News & Alerts
Brainsway Ltd. Sponsored ADR (BWAY) Hit a 52 Week High, Can the Run Continue? - ca.finance.yahoo.com
Surging Earnings Estimates Signal Upside for Brainsway (BWAY) Stock - NewsBreak: Local News & Alerts
Wall Street Analysts Think Brainsway (BWAY) Could Surge 25.58%: Read This Before Placing a Bet - Yahoo Finance
Northland Capmk Predicts Stronger Earnings for Brainsway - Defense World
Research Analysts Set Expectations for Brainsway Q3 Earnings - Defense World
What is HC Wainwright’s Estimate for Brainsway Q3 Earnings? - Defense World
Brainsway (NASDAQ:BWAY) Price Target Raised to $19.00 at Northland Securities - Defense World
Brainsway (BWAY) Projected to Post Quarterly Earnings on Wednesday - Defense World
Buy These 4 Stocks With Solid Net Profit Margin to Maximize Returns - The Globe and Mail
Finanzdaten der Brainsway Ltd Adr-Aktie (BWAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):